NADMED develops and provides a method for measuring NAD molecules in biological samples. The company offers a solution that claims to be more accurate, reliable, and cost-effective compared to other methods.

NADMED

NADMED Oy is a startup company bringing to market a new accurate high-throughput method to measure NADs from whole blood and other sample matrices.

Voima Ventures

NADMED Ltd.

Fantastic news! 

NADMED secures €3.5M to accelerate international sales expansion. 

The investment round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured from previous investors Voima Ventures and University of Helsinki Funds, from a number of private European investors, and a grant from Business Finland. Read more here: https://lnkd.in/dbP-2CQc #NAD #NADMED #NSI #investment

NADMED is back from vacation and fully operational. Join us next week at the FASEB meeting in Lisbon and the ARDD in Copenhagen. Visit our booth to learn about our latest advancements. #NAD #NADMED #FASEB #ARDD

As a researcher, you know that currently available #NAD measuring kits are not accurate enough to provide meaningful results AND as a lab manager, you know the traditional methods like mass spectrometry or present colorimetric kits come with their characteristic problems: accuracy, time, and cost. 

This is where NADMED’s technology is different!  

With over 40,000 measurements taken to date, a CE-marked kit, and FDA clearance coming soon, start utilizing NADMED today and start measuring with better outcomes.

Contact us today or visit us at #ADLM this week to order a #NADMED kit and start measuring smarter! 

Find us at Booth SC-7 in the DxPx Startup City Space!

https://loom.ly/QWV7IbA

As a pharmaceutical executive, we know how important cost, efficiency, and accuracy are to you.

Looking to lower your testing costs by over 60% and utilize an efficient, purpose-built assay for all forms of #NAD and glutathione?  

Contact us today or visit us at #ADLM this week to order a #NADMED kit and start measuring smarter! 

Find us at Booth SC-7 in the DxPx Startup City Space.

https://loom.ly/QWV7IbA

See you in Copenhagen! #NAD #NADMED #ARDD

The caravan keeps moving! Now back in Helsinki for the EAN Conference. If you're around, come say hello. #NAD #NADMED #mitochondria #neurology

Lacking energy? Meet our team in Basel at Future Labs 2024. Booth S229.

We are extremely proud to be part of this magnificent work that Clene Nanomedicine does with Parkinson's research. #CleneNanomedicine #ParkinsonsResearch #MichaelJFoxFoundation

DxPx Welcomes NADMED, a pioneer in NAD+ & Glutathione measurement technology, to Startup City!

NADMED Ltd. is a developer of NAD measuring technology designed for extracting and measuring nicotinamide adenine dinucleotides and glutathiones. NADMED offers a non-destructive extraction & quantification method for vital cellular components. For more information, visit: https://hubs.ly/Q02BPKGf0

Limited booths are available for Startup City! Use code SCB2024 for 20% off through June 21st! 

Secure your booth here: https://hubs.ly/Q02BQc3q0 

Thank you to our sponsors Association for Diagnostics & Laboratory Medicine, McDermott Will & Emery, AdvaMed Destination Medical Center (DMC), Greenberg Traurig, LLP, QIAGEN, Tosoh USA, Inc., We Venture Capital!

#StartupCity #Exhibitors #DxPxUS2024 #ADLM2024 #NADMED

Come meet us in Dublin! The Longevity Summit Dublin starts tomorrow, and we're excited to share the latest updates on NAD and its measurement. #NAD #NADMED #longevitysummitdublin

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 23, 2024 4:57 AM	67662370
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 23, 2024 4:57 AM	c1b4d45c
translate crunchbase fundingrounds	general
peers	general	Aug 23, 2024 4:57 AM	b8087b48
news basic	general	Aug 23, 2024 4:57 AM	c03fafc6
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NADM

COM:NADMED

NADMED